Skip to main content
13 August 2026
20 August 2025

Nilesh Shah joins Illumina as Head of Region, AMEA

Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately. Nilesh brings over 25 years of leadership experience in the medical technology and life sciences industries, having held senior roles at Johnson &…

19 August 2025

Exactech Announces CEO Transition

Exactech, a global medical technology leader, announced that Aurelio Sahagun will serve as the Chief Executive Officer of the new company's business upon the closing of the pending sale, which is expected as soon as October. Mr. Sahagun will succeed current CEO Darin Johnson, who will assist in the leadership transiti…

19 August 2025

Zynex Strengthens Leadership with New CEO and Key Appointments

Zynex, Inc , an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company.  On June 30…

13 August 2025

Rezo Therapeutics Appoints Derek Hicks as CEO

Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, announced that Derek Hicks was appointed CEO. With more than 25 years of leadership in the pharmaceutical and biotech sectors, Derek brings a strong track record of transformative business devel…

12 August 2025

Brenntag Specialties CEO Michael Friede to Step Down in November 2025

Michael Friede, Chief Executive Officer Brenntag Specialties and member of the Board of Management of Brenntag SE, the global market leader in chemicals and ingredients distribution, has informed the Supervisory Board of Brenntag SE that he will not extend his contract which ends on March 31, 2026. He will leave the c…

31 July 2025

Leadership Transition at Emerald Clinical Trials: Glenn Kerkhof Steps In

Emerald Clinical Trials, a leading global clinical research organization, announced a leadership transition. Mary Gunn has stepped down effective immediately. The Board has appointed Glenn Kerkhof, a long-standing Board member and experienced CRO executive, as Interim CEO. The Board has commenced a formal search for …

30 July 2025

Hansa Biopharma announces key executive appointments to support continued growth

Hansa Biopharma AB, announced three leadership appointments. Brian Gorman joins Hansa as Chief Legal Officer and Corporate Secretary, effective August 4; Sandra Frithiof has been appointed Chief Human Resources Officer (CHRO), effective August 4; and Kerstin Falck Lagercrantz will join the company September 1, as Vice…

23 July 2025

Abzena Appoints Geoffrey M. Glass as CEO to Lead Next Phase of Growth

Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced that Geoffrey M. Glass has been appointed Chief Executive Officer (CEO), effective immediately. Mr. Glass has served as Chairman of the Board since 2022. Mr. Glass brings 30 years of experience in the life sciences…

22 July 2025

Avantor Welcomes Emmanuel Ligner as President and CEO

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025. Mr. Ligner succeeds Michael Stubblefield, who will, as…

11 July 2025

Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer

Jazz Pharmaceuticals plc announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's President and Chief Operating Officer, as the President and Chief Executive Officer, effective August 11, 2025, when she will also join the Board. She will succeed co-founder, Chairperson and CEO Bruce Cozad…

Page 9 of 14